| scholarly article | Q13442814 |
| P50 | author | Patrick A. Baeuerle | Q113868 |
| Lea Eisenbach | Q59696159 | ||
| P2093 | author name string | D Plaksin | |
| P2860 | cites work | I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 |
| Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65 | Q24309237 | ||
| Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus | Q24337591 | ||
| The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 | ||
| NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit | Q24561421 | ||
| The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B | Q24564667 | ||
| Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines | Q24605501 | ||
| Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
| Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells | Q27860599 | ||
| The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition | Q28155838 | ||
| The inducible transcription activator NF-kappa B: regulation by distinct protein subunits | Q28274350 | ||
| H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element | Q28508930 | ||
| Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression | Q28587941 | ||
| Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B | Q28645847 | ||
| Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal | Q29618196 | ||
| The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product | Q29618249 | ||
| Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity | Q29618284 | ||
| Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA | Q29620537 | ||
| Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene | Q33582592 | ||
| TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors | Q33609443 | ||
| Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers | Q33929799 | ||
| The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50 | Q33938198 | ||
| DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide | Q34088506 | ||
| Selective changes in expression of HLA class I polymorphic determinants in human solid tumors | Q34301621 | ||
| Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit | Q34357628 | ||
| A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes | Q34616824 | ||
| Regulation of murine class I genes by interferons is controlled by regions located both 5' and 3' to the transcription initiation site | Q34624493 | ||
| Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells | Q35234796 | ||
| Many transcription factors interact synergistically with steroid receptors | Q67985336 | ||
| Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas | Q68032800 | ||
| Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro | Q68111216 | ||
| The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes | Q69026379 | ||
| Regulation of HLA class I transcription in T cells | Q69787697 | ||
| Functional analysis of the mouse H-2Kb gene promoter in embryonal carcinoma cells | Q70090193 | ||
| MHC imbalance and metastatic spread in Lewis lung carcinoma clones | Q71765267 | ||
| Presentation of antigenic peptides by MHC class I molecules | Q75292704 | ||
| The nucleotide sequence of the rat cytoplasmic β–actin gene | Q35672782 | ||
| NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats | Q35875812 | ||
| Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer | Q36350013 | ||
| Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. | Q36356077 | ||
| Functional expression of a mouse H-2Kb gene isolated from non-expressing teratocarcinoma cells | Q36624910 | ||
| Antigen presentation: structural themes and functional variations | Q36659704 | ||
| Retinoic acid-dependent transactivation of major histocompatibility complex class I promoters by the nuclear hormone receptor H-2RIIBP in undifferentiated embryonal carcinoma cells | Q36810921 | ||
| Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene | Q36833546 | ||
| Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression | Q36957042 | ||
| Expression of a preproinsulin-beta-galactosidase gene fusion in mammalian cells | Q37347001 | ||
| Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter | Q37485004 | ||
| NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes | Q38328214 | ||
| Activity of the kappa B enhancer of the interleukin-2 receptor alpha chain in somatic cell hybrids is accompanied by the nuclear localization of NF-kappa B | Q38332626 | ||
| Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. | Q38336043 | ||
| The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences | Q38336346 | ||
| DNA binding of regulatory factors interacting with MHC-class-I gene enhancer correlates with MHC-class-I transcriptional level in class-I-defective cell lines | Q38337374 | ||
| A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes | Q38339859 | ||
| Major histocompatibility complex class I genes in murine fibrosarcoma IC9 are down regulated at the level of the chromatin structure | Q40646985 | ||
| The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties | Q40820614 | ||
| The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines | Q40820623 | ||
| Identification of sequences responsible for positive and negative regulation by E1A in the promoter of H-2Kbm1 class I MHC gene | Q41200298 | ||
| DNA sequence analysis of the C3H H-2Kk and H-2Dk loci. Evolutionary relationships to H-2 genes from four other mouse strains | Q41303549 | ||
| The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation | Q41514176 | ||
| Regulation of gene expression by interferons: control of H-2 promoter responses | Q42098641 | ||
| Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: Evidence using monoclonal antibodies | Q42449305 | ||
| Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. | Q42799960 | ||
| Differential expression of H-2 gene products in tumour cells in associated with their metastatogenic properties | Q42802345 | ||
| The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. | Q42822926 | ||
| Loss of polymorphic A and B locus HLA antigens in colon carcinoma | Q43050288 | ||
| HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas | Q43050854 | ||
| Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma | Q43489693 | ||
| c-fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence. | Q44189446 | ||
| Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells | Q44899739 | ||
| H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide | Q45084111 | ||
| A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. | Q45142085 | ||
| I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family | Q46153930 | ||
| Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. | Q52832672 | ||
| Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B | Q54270780 | ||
| Loss of expression of transplantation antigens encoded by the H-2K locus on Lewis lung carcinoma cells and its relevance to the tumor's metastatic properties | Q54495181 | ||
| Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia. | Q54524583 | ||
| SELECTIVE LOSS OF HLA-A,B,C LOCUS PRODUCTS IN COLORECTAL ADENOCARCINOMA | Q57337256 | ||
| Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity | Q57541531 | ||
| Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H–2 gene | Q59081319 | ||
| H-2Db gene transfer into highly metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients. Implications for mechanisms of allorejection | Q67577416 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 1651-1662 | |
| P577 | publication date | 1993-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells | |
| P478 | volume | 177 |
| Q40246228 | (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit |
| Q40761786 | A T cell-specific enhancer of the human CD40 ligand gene |
| Q38355620 | A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells |
| Q39640071 | Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis |
| Q41829978 | Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention |
| Q39002185 | Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo |
| Q35834615 | An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis |
| Q37398298 | Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity |
| Q42260610 | Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter |
| Q40018450 | Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo |
| Q36225743 | EHMT1 protein binds to nuclear factor-κB p50 and represses gene expression |
| Q36591837 | Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-kappaB |
| Q40370035 | Enhancement of NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells. |
| Q37391100 | Enhancing the recognition of tumour associated antigens. |
| Q36556942 | Evidence for the involvement of a nuclear NF-kappa B inhibitor in global down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells |
| Q74460729 | Excretory/secretory products from plerocercoids of Spirometra erinaceieuropaei suppress the TNF-alpha gene expression by reducing phosphorylation of ERK1/2 and p38 MAPK in macrophages |
| Q40551597 | From Aristotle, through Spemann, to tumor immunology: a personal experience. |
| Q39540152 | Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. |
| Q58610858 | Gain-of-function mutation causes human combined immune deficiency |
| Q40185662 | Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes |
| Q38311419 | HLA class I antigen downregulation by interleukin (IL)-10 is predominantly governed by NK-kappaB in the short term and by TAP1+2 in the long term. |
| Q40023974 | Helicobacter pylori-induced H,K-ATPase alpha-subunit gene repression is mediated by NF-kappaB p50 homodimer promoter binding |
| Q38363101 | IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. |
| Q35115637 | Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses |
| Q36566451 | Identification of the rel family members required for virus induction of the human beta interferon gene |
| Q42481352 | Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis |
| Q39822031 | Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages. |
| Q40476139 | Lipopolysaccharide induces 5-lipoxygenase-activating protein gene expression in THP-1 cells via a NF-kappaB and C/EBP-mediated mechanism. |
| Q29547864 | Missing pieces in the NF-kappaB puzzle |
| Q28397259 | Mitochondria and reactive oxygen species: physiology and pathophysiology |
| Q34998247 | Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes |
| Q28575104 | Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy |
| Q28215631 | Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers |
| Q37377834 | NF-kappaB mediates mitogen-activated protein kinase pathway-dependent iNOS expression in human melanoma |
| Q41767515 | Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling |
| Q52311688 | Nuclear Factor-kappaB in Autoimmunity: Man and Mouse. |
| Q38358818 | Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression |
| Q35741937 | Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies |
| Q43681634 | Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia |
| Q40838191 | Oscillating fluid flow inhibits TNF-alpha -induced NF-kappa B activation via an Ikappa B kinase pathway in osteoblast-like UMR106 cells |
| Q28371975 | Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA |
| Q39119033 | Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα. |
| Q39444910 | Reduced phosphorylation of p50 is responsible for diminished NF-kappaB binding to the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells |
| Q21296830 | Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages |
| Q24296921 | Regulation of human LZIP expression by NF-kappaB and its involvement in monocyte cell migration induced by Lkn-1 |
| Q40160616 | Regulation of porcine classical and nonclassical MHC class I expression |
| Q34465473 | Ribosomal proteins: functions beyond the ribosome |
| Q40912575 | Role of p52 (NF-kappaB2) in LPS tolerance in a human B cell line |
| Q21090517 | Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism |
| Q33814017 | Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus |
| Q27640073 | Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation |
| Q91704213 | Stable intronic sequence RNAs (sisRNAs) are selected regions in introns with distinct properties |
| Q42198449 | TNF induction of jagged-1 in endothelial cells is NFkappaB-dependent |
| Q40729355 | Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization |
| Q33655868 | Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling |
| Q35194794 | The E3 ligase c-Cbl regulates dendritic cell activation |
| Q24293229 | The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1 |
| Q39587742 | The specificity of innate immune responses is enforced by repression of interferon response elements by NF-κB p50 |
Search more.